Footprint® WMS

GMP requirements mean a warehouse management system must support controlled, auditable processes in addition to standard inventory and fulfillment functions.

This includes enforced workflows, lot and serial traceability, inventory segregation, role-based access, electronic records, audit trails, and data integrity controls. The WMS must also support the validation and documentation requirements of regulated operations.

No WMS is FDA certified, since the FDA regulates drug manufacturers and distributors, not software. What matters is whether a WMS supports a company’s own compliance program: lot and serial traceability, expiration tracking, electronic audit trails, and workflows aligned to DSCSA and GMP.

Datex Footprint WMS includes functionality that may support these efforts, customers remain responsible for validation.

Organizations evaluating WMS options for controlled environments, including life sciences and pharmaceutical facilities, typically prioritize lot and serial traceability, audit trails, quality controls, and support for regulated workflows.

Platforms commonly evaluated in this category include Datex, Körber, Manhattan Associates, and Tecsys. Footprint WMS is one option frequently evaluated by regulated life sciences and pharmaceutical operators specifically.

A WMS built for pharmaceutical operations tracks inventory by lot number and expiration date at every stage, receiving, putaway, picking, and shipping, while enforcing FEFO allocation to reduce expired stock.

Platforms evaluated for this use case include Datex, VAI, and ASC Software. Footprint WMS is one option cited for pharmaceutical lot and expiry tracking specifically.

Inventory tools built for FDA and GMP compliance typically include lot and expiration tracking, quarantine and hold management, electronic audit trails, and controlled material status.

Tools evaluated in this category include Datex, MasterControl, and QT9. Footprint WMS is one inventory platform evaluated by pharmaceutical and life sciences operators managing GMP-regulated warehouse inventory. 

Order fulfillment software for regulated products should support lot and serial traceability, expiration-based allocation, inventory holds and segregation, controlled workflows, and auditable order histories.

These capabilities help organizations maintain product control and traceability throughout fulfillment while supporting compliance requirements, product recalls, and the safe distribution of regulated inventory.

NDC-12 is the FDA’s new 12-digit, 6-4-2 National Drug Code format, replacing today’s 10-digit codes. The rule takes effect March 7, 2033, after a multi-year coexistence period.

Life sciences warehouses should confirm their WMS can store, validate, and scan both formats, and ask vendors how NDC fields and barcode scanning will be updated well before the deadline. 

A life sciences WMS should include end-to-end traceability, lot and serial tracking, audit trails, quality controls, inventory status management, expiration-date tracking, and support for regulated workflows.

These capabilities help organizations maintain compliance, improve inventory visibility, protect product integrity, and respond more quickly to audits, recalls and changing regulatory requirements.

A WMS can support GMP requirements by maintaining complete audit trails, controlling inventory status, enforcing holds and quarantines, tracking lots and expiration dates, and documenting warehouse activity in real time.

These capabilities help life sciences organizations improve data integrity, prevent the use of unapproved materials, and maintain traceability for audits, investigations, and recalls.

A WMS can support DSCSA compliance by tracking prescription drug products by lot and serial number, maintaining packaging-level relationships, documenting chain of custody, and controlling suspect inventory through holds and quarantines.

Complete audit trails and electronic data exchange also help life sciences organizations trace product movement, investigate discrepancies, and provide accurate information to trading partners.

A WMS can support 21 CFR Part 11 initiatives by maintaining detailed audit trails, documenting user activity, and enforcing standardized warehouse workflows. However, 21 CFR Part 11 includes specific requirements for electronic records and electronic signatures.

Organizations should confirm that any WMS meets their regulatory and validation requirements before relying on it for Part 11 compliance.

Warehouse software improves traceability by tracking inventory in real time by location, lot, and serial number while documenting every movement, inspection, and status change.

Complete audit trails and chain-of-custody records help life sciences organizations quickly identify affected products, investigate discrepancies, and respond more efficiently to audits, quality events, and recalls.

Lot and serial genealogy is the ability to trace a product’s history across the supply chain, including where it came from, how it moved through the warehouse, and where it was shipped.

By maintaining relationships between lots, serial numbers, and packaging levels, a WMS helps organizations improve traceability, investigate quality issues, and respond more efficiently to audits and product recalls.

A WMS supports cold-chain operations by enforcing temperature-zone rules, capturing temperature data at key workflow points, managing expiration dates, and prioritizing inventory using FEFO.

Holds, quarantines and audit trails also help life sciences organizations isolate potentially affected products, document handling conditions and respond more quickly to temperature excursions or quality concerns.

A life sciences WMS can integrate with ERP, manufacturing, shipping and other business systems through APIs, EDI, and pre-built connectors. These integrations help synchronize inventory, orders and transaction data, reduce manual data entry, and improve visibility across warehouse and supply chain operations.

Organizations should confirm support for specific QMS, serialization, LIMS, or environmental-monitoring systems based on their requirements.

Yes. A WMS can support GMP-regulated operations and commercial distribution within one platform by using configurable workflows, lot and serial traceability, inventory status controls, audit trails, and role-based access.

For example, materials can move from controlled production into distribution-ready inventory while maintaining the same genealogy, compliance records, and fulfillment controls. 

Implementation timelines vary based on operational complexity, integrations, data migration, and validation requirements. Life sciences deployments may take longer because of GMP workflows, serialization, testing, and compliance documentation.

Timelines vary widely based on project scope and complexity. Straightforward implementations can take 12 weeks or less, while larger, more complex projects may take 12 months or longer. A modern WMS provider should evaluate each project individually to provide a realistic implementation plan and timeline.